Ashutosh Kumar1, Goru Bhawani2, Neera Kumari3, Kasturi Sn Murthy4, Vinod Lalwani5, Ch Narasimha Raju5. 1. Assistant Professor, Department of Cardiology, GSL Medical College and Hospital , Rajahmundry, India . 2. Associate Professor, Department of Pharmacology, GSL Medical College & Hospital , Rajahmundry, India . 3. Assistant Professor, Department of Physiology, Sri Krishna Medical College , Muzzafarpur, India . 4. Head of the Department, Department of Pharmacolgy, GSL Medical College & Hospital , Rajahmundry, India . 5. Junior Resident, Department of Cardiology, GSL Medical College Rajahmundry, India .
Abstract
UNLABELLED: Objectives : To evaluate the difference in the renal protective effects of allopurinol and n-acetyl cysteine along with saline hydration in patients of contrast induced nephropathy (CIN) post cardiac interventions. BACKGROUND:CIN remains a common complication of cardiac procedures. Radio contrast agents can cause a reduction in renal function that may be related to oxidative stress underlining various patho- physiologies. Conflicting evidence suggests that administration of allopurinol, a xanthine oxidase inhibitor can prevent CIN. MATERIALS AND METHODS: This is a study of 500 patients undergoing angiography and coronary revascularisation in patients showing significant coronary block. The angiography positive patients (275) were prospectively randomised to different treatment protocol to study for their reno-protective effect. The patients received either of the three drugs saline hydration (SH, 1ml/kg/hr), n-acetylcysteine (SH+NAC, 600 mg bd) or Allopurinol (SH+ALLP, 300 mg/day) 12 hours before and after administration of radio contrast agent. Levels of serum creatinine and blood urea of the 275 patients recorded at 24 hour interval were noted post angioplasty over a course of 5 days in patients receiving either omnipaque (125) or visipaque (150) contrast media. All the 500 patients were also assessed for development of any kind of adverse drug effects/reactions with the two contrast media. RESULTS:CIN occurred in 56 of 500 the patients (10.6%) who underwent angiography and 49 of 275 patients (17.8%) who underwent angioplasty. In the omnipaque group CIN occurred in 16/40, 8/40, nil/45 in patients receiving SH, NAC plus SH and SH plus ALLP respectively. In the visipaque group CIN occurred in 15/50, 10/50, nil/50 in the three treatments groups respectively. Allopurinol maintained a consistent fall in the serum creatinine & blood urea levels from the baseline values from the end of the 1(st) day (p < .01 & .001) in both the category. Visipaque proved to be better dye than omnipaque with less adverse drug effects/ reactions. CONCLUSION: Prophylactic oral administration of allopurinol (300 mg/day) along with hydration is better than n-acetylcysteine and saline hydration alone for protection against CIN in patients undergoing coronary procedures.
RCT Entities:
UNLABELLED: Objectives : To evaluate the difference in the renal protective effects of allopurinol and n-acetyl cysteine along with saline hydration in patients of contrast induced nephropathy (CIN) post cardiac interventions. BACKGROUND:CIN remains a common complication of cardiac procedures. Radio contrast agents can cause a reduction in renal function that may be related to oxidative stress underlining various patho- physiologies. Conflicting evidence suggests that administration of allopurinol, a xanthine oxidase inhibitor can prevent CIN. MATERIALS AND METHODS: This is a study of 500 patients undergoing angiography and coronary revascularisation in patients showing significant coronary block. The angiography positive patients (275) were prospectively randomised to different treatment protocol to study for their reno-protective effect. The patients received either of the three drugs saline hydration (SH, 1ml/kg/hr), n-acetylcysteine (SH+NAC, 600 mg bd) or Allopurinol (SH+ALLP, 300 mg/day) 12 hours before and after administration of radio contrast agent. Levels of serum creatinine and blood urea of the 275 patients recorded at 24 hour interval were noted post angioplasty over a course of 5 days in patients receiving either omnipaque (125) or visipaque (150) contrast media. All the 500 patients were also assessed for development of any kind of adverse drug effects/reactions with the two contrast media. RESULTS:CIN occurred in 56 of 500 the patients (10.6%) who underwent angiography and 49 of 275 patients (17.8%) who underwent angioplasty. In the omnipaque group CIN occurred in 16/40, 8/40, nil/45 in patients receiving SH, NAC plus SH and SH plus ALLP respectively. In the visipaque group CIN occurred in 15/50, 10/50, nil/50 in the three treatments groups respectively. Allopurinol maintained a consistent fall in the serum creatinine & blood urea levels from the baseline values from the end of the 1(st) day (p < .01 & .001) in both the category. Visipaque proved to be better dye than omnipaque with less adverse drug effects/ reactions. CONCLUSION: Prophylactic oral administration of allopurinol (300 mg/day) along with hydration is better than n-acetylcysteine and saline hydration alone for protection against CIN in patients undergoing coronary procedures.
Authors: Laura G Sánchez-Lozada; Edilia Tapia; José Santamaría; Carmen Avila-Casado; Virgilia Soto; Tomás Nepomuceno; Bernardo Rodríguez-Iturbe; Richard J Johnson; Jaime Herrera-Acosta Journal: Kidney Int Date: 2005-01 Impact factor: 10.612
Authors: Daniel I Feig; Takahiko Nakagawa; S Ananth Karumanchi; William J Oliver; Duk-Hee Kang; Jennifer Finch; Richard J Johnson Journal: Kidney Int Date: 2004-07 Impact factor: 10.612
Authors: A Ahsan Ejaz; Wei Mu; Duk-Hee Kang; Carlos Roncal; Yuri Y Sautin; George Henderson; Isabelle Tabah-Fisch; Birgit Keller; Thomas M Beaver; Takahiko Nakagawa; Richard J Johnson Journal: Clin J Am Soc Nephrol Date: 2006-12-06 Impact factor: 8.237
Authors: T Erol; A Tekin; M T Katırcıbaşı; N Sezgin; M Bilgi; G Tekin; A Zümrütdal; A T Sezgin; H Müderrisoğlu Journal: Int J Cardiol Date: 2012-05-08 Impact factor: 4.164
Authors: Richard J Johnson; George L Bakris; Claudio Borghi; Michel B Chonchol; David Feldman; Miguel A Lanaspa; Tony R Merriman; Orson W Moe; David B Mount; Laura Gabriella Sanchez Lozada; Eli Stahl; Daniel E Weiner; Glenn M Chertow Journal: Am J Kidney Dis Date: 2018-02-27 Impact factor: 8.860
Authors: Ana Andres-Hernando; Nanxing Li; Christina Cicerchi; Shinichiro Inaba; Wei Chen; Carlos Roncal-Jimenez; Myphuong T Le; Michael F Wempe; Tamara Milagres; Takuji Ishimoto; Mehdi Fini; Takahiko Nakagawa; Richard J Johnson; Miguel A Lanaspa Journal: Nat Commun Date: 2017-02-13 Impact factor: 14.919
Authors: Abutaleb Ahsan Ejaz; Takahiko Nakagawa; Mehmet Kanbay; Masanari Kuwabara; Ada Kumar; Fernando E Garcia Arroyo; Carlos Roncal-Jimenez; Fumihiko Sasai; Duk-Hee Kang; Thomas Jensen; Ana Andres Hernando; Bernardo Rodriguez-Iturbe; Gabriela Garcia; Dean R Tolan; Laura G Sanchez-Lozada; Miguel A Lanaspa; Richard J Johnson Journal: Semin Nephrol Date: 2020-11 Impact factor: 5.299